These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 24138426)

  • 21. New therapeutic strategies with combined renin-angiotensin system inhibitors for pediatric nephropathy.
    Zaffanello M; Franchini M; Fanos V
    Pharmacotherapy; 2008 Jan; 28(1):125-30. PubMed ID: 18154482
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The angiotensin-converting enzyme 2/angiotensin-(1-7)/Mas receptor axis: a potential target for treating thrombotic diseases.
    Fraga-Silva RA; Da Silva DG; Montecucco F; Mach F; Stergiopulos N; da Silva RF; Santos RA
    Thromb Haemost; 2012 Dec; 108(6):1089-96. PubMed ID: 23093373
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel insight into the pathobiology of abdominal aortic aneurysm and potential future treatment concepts.
    Diehm N; Dick F; Schaffner T; Schmidli J; Kalka C; Di Santo S; Voelzmann J; Baumgartner I
    Prog Cardiovasc Dis; 2007; 50(3):209-17. PubMed ID: 17976505
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preadmission use of renin-angiotensin blockers and rupture of abdominal aortic aneurysm: a nationwide, population-based study.
    Wemmelund H; Høgh A; Hundborg HH; Johnsen SP; Lindholt JS
    Pharmacoepidemiol Drug Saf; 2016 Feb; 25(2):141-50. PubMed ID: 26817783
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ACE inhibitors and angiotensin II receptor antagonists in Crohn's disease management.
    Hume GE; Radford-Smith GL
    Expert Rev Gastroenterol Hepatol; 2008 Oct; 2(5):645-51. PubMed ID: 19072342
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevention of remodeling in congestive heart failure due to myocardial infarction by blockade of the renin-angiotensin system.
    Guo X; Saini HK; Wang J; Gupta SK; Goyal RK; Dhalla NS
    Expert Rev Cardiovasc Ther; 2005 Jul; 3(4):717-32. PubMed ID: 16076281
    [TBL] [Abstract][Full Text] [Related]  

  • 27. On target to dual block RAS?
    Papadopoulos DP; Papademetriou V; Makris TK
    Angiology; 2009 Dec-2010 Jan; 60(6):739-49. PubMed ID: 19144653
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Update on new aspects of the renin-angiotensin system in liver disease: clinical implications and new therapeutic options.
    Grace JA; Herath CB; Mak KY; Burrell LM; Angus PW
    Clin Sci (Lond); 2012 Aug; 123(4):225-39. PubMed ID: 22548407
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Blockade of the renin-angiotensin system by a combination of ACE inhibitors and AT1 receptor antagonists].
    Azizi M
    Rev Prat; 2004 Jun; 54(11):1167-74. PubMed ID: 15496022
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rationale for combining blockers of the renin-angiotensin system.
    Azizi M; Wuerzner G
    Semin Nephrol; 2007 Sep; 27(5):544-54. PubMed ID: 17868792
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The renin system: is direct renin inhibition different from blockade at the AT1 receptor or the ACE step?
    Hollenberg NK
    Rev Cardiovasc Med; 2007; 8 Suppl 2():S7-13. PubMed ID: 17401314
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rationale for the use of combination angiotensin-converting enzyme inhibitor/angiotensin II receptor blocker therapy in heart failure.
    Carson PE
    Am Heart J; 2000 Sep; 140(3):361-6. PubMed ID: 10966531
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of angiotensin receptor blockers in the prevention and treatment of arrhythmias.
    Garg S; Narula J; Marelli C; Cesario D
    Am J Cardiol; 2006 Mar; 97(6):921-5. PubMed ID: 16516603
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of the renin-angiotensin system in aortic aneurysmal diseases.
    Lu H; Rateri DL; Cassis LA; Daugherty A
    Curr Hypertens Rep; 2008 Apr; 10(2):99-106. PubMed ID: 18474175
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [RAS blockade].
    Jin C; Ito S
    Nihon Rinsho; 2004 Oct; 62(10):1880-4. PubMed ID: 15500134
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The renin-angiotensin system and diabetic nephropathy.
    Gurley SB; Coffman TM
    Semin Nephrol; 2007 Mar; 27(2):144-52. PubMed ID: 17418683
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-diabetic effect of blockade of the renin-angiotensin system.
    Ando K; Fujita T
    Diabetes Obes Metab; 2006 Jul; 8(4):396-403. PubMed ID: 16776746
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of the renin-angiotensin system prevents seizures in a rat model of epilepsy.
    Pereira MG; Becari C; Oliveira JA; Salgado MC; Garcia-Cairasco N; Costa-Neto CM
    Clin Sci (Lond); 2010 Aug; 119(11):477-82. PubMed ID: 20533906
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of genetic variation on therapy with angiotensin converting enzyme inhibitors or angiotensin receptor blockers in dialysis patients.
    Böger CA; Götz AK; Krüger B; Hösl M; Schmitz G; Riegger GA; Krämer BK
    Eur J Med Res; 2005 Apr; 10(4):161-8. PubMed ID: 15946912
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel therapies blocking the renin-angiotensin-aldosterone system in the management of hypertension and related disorders.
    Krum H; Gilbert RE
    J Hypertens; 2007 Jan; 25(1):25-35. PubMed ID: 17143168
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.